Skip to content

Septorhinoplasty and Pain Score Course

The Relationship of Pain Score Course and Analgesic Intervention Timing With Clinical Outcomes in the Postanesthetic Period After Septorhinoplasty

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07015229
Enrollment
78
Registered
2025-06-11
Start date
2025-06-25
Completion date
2026-01-20
Last updated
2025-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Analogue Scale

Brief summary

To provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the postanesthetic care unit.

Interventions

To provide scientific contribution to more effective and timely pain management strategies in the postoperative period by evaluating the time-dependent course of pain scores and the effect of analgesic intervention timing on clinical outcomes in patients who underwent septorhinoplasty and who are followed in the postanesthetic care unit.

Sponsors

Istinye University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Being 18 years of age or older, * Being in ASA I-III class, * Having undergone septorhinoplasty surgery under general anesthesia under elective conditions, * Being monitored for at least 30 minutes in postoperative, * Being conscious and able to assess pain with VAS.

Exclusion criteria

* Patients who have undergone surgical procedures other than septorhinoplasty (e.g. laparoscopic, gynecological, orthopedic, etc.) * Inability to assess pain due to impaired consciousness, agitation, or sedation in the postoperative period * History of opioid derivatives or continuous analgesic use in the preoperative period * Cognitive impairment, psychiatric disease at a level that prevents communication, severe visual or hearing impairment * History of neurological or neuromuscular disease * Having undergone revision septorhinoplasty or other revision surgery * Patients with VAS≥4 during their follow-up in the postoperative,

Design outcomes

Primary

MeasureTime frameDescription
visual analogue scale60 minutes0:no pain, 10:worst pain

Contacts

Primary Contactilke dolgun
ilkeser2004@gmail.com+905555485632

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026